We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
35 hedge funds and large institutions have $53.8M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $62M → $53.8M (-$8.23M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $193K
Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
8
Reduced
12
Closed
2
Calls
–
Puts
$193K
Net Calls
-$193K
Net Calls Change
+$166K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.55M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$329K |
| 3 |
Renaissance Technologies
New York
|
+$150K |
| 4 |
JP Morgan Chase
New York
|
+$142K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$11.3K |
